Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Eton receives FDA acceptance for NDA filing for zonisamide oral suspension » 08:34
10/15/20
10/15
08:34
10/15/20
08:34
ETON

Eton Pharmaceuticals

$7.75 /

+0.82 (+11.83%)

Eton Pharmaceuticals…

Eton Pharmaceuticals announced the U.S. Food and Drug Administration has accepted for filing the company's new drug application for zonisamide oral suspension. The application has been assigned a Prescription Drug User Fee Act date of May 29, 2021. The application was submitted for the treatment of partial seizures in patients with epilepsy. Zonisamide is one of Eton's three neurology-focused oral liquid product candidates that have been submitted to the FDA, and all three product candidates are expected to be approved and launched in 2021.

ShowHide Related Items >><<
ETON Eton Pharmaceuticals
$7.75 /

+0.82 (+11.83%)

ETON Eton Pharmaceuticals
$7.75 /

+0.82 (+11.83%)

09/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $20 from $18 at H.C. Wainwright
07/28/20 Lake Street
Eton 'on cusp' of generating significant shareholder value, says Lake Street
05/26/20 H.C. Wainwright
Eton Pharmaceuticals price target lowered to $18 from $26 at H.C. Wainwright
03/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $26 from $23 at H.C. Wainwright
ETON Eton Pharmaceuticals
$7.75 /

+0.82 (+11.83%)

  • 16
    Oct
ETON Eton Pharmaceuticals
$7.75 /

+0.82 (+11.83%)

Hot Stocks
Eton Pharmaceuticals up 4.6% at $7.25 after pricing secondary above prior close  08:37
10/14/20
10/14
08:37
10/14/20
08:37
ETON

Eton Pharmaceuticals

$6.93 /

+0.02 (+0.29%)

 
ShowHide Related Items >><<
ETON Eton Pharmaceuticals
$6.93 /

+0.02 (+0.29%)

ETON Eton Pharmaceuticals
$6.93 /

+0.02 (+0.29%)

09/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $20 from $18 at H.C. Wainwright
07/28/20 Lake Street
Eton 'on cusp' of generating significant shareholder value, says Lake Street
05/26/20 H.C. Wainwright
Eton Pharmaceuticals price target lowered to $18 from $26 at H.C. Wainwright
03/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $26 from $23 at H.C. Wainwright
ETON Eton Pharmaceuticals
$6.93 /

+0.02 (+0.29%)

  • 16
    Oct
ETON Eton Pharmaceuticals
$6.93 /

+0.02 (+0.29%)

Syndicate
Eton Pharmaceuticals 2.8M share Secondary priced at $7.00 » 08:34
10/14/20
10/14
08:34
10/14/20
08:34
ETON

Eton Pharmaceuticals

$6.93 /

+0.02 (+0.29%)

The deal priced above the…

The deal priced above the last closing price of $6.93. National Securities is acting as sole book running manager for the offering.

ShowHide Related Items >><<
ETON Eton Pharmaceuticals
$6.93 /

+0.02 (+0.29%)

ETON Eton Pharmaceuticals
$6.93 /

+0.02 (+0.29%)

09/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $20 from $18 at H.C. Wainwright
07/28/20 Lake Street
Eton 'on cusp' of generating significant shareholder value, says Lake Street
05/26/20 H.C. Wainwright
Eton Pharmaceuticals price target lowered to $18 from $26 at H.C. Wainwright
03/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $26 from $23 at H.C. Wainwright
ETON Eton Pharmaceuticals
$6.93 /

+0.02 (+0.29%)

  • 16
    Oct
ETON Eton Pharmaceuticals
$6.93 /

+0.02 (+0.29%)

Syndicate
Eton Pharmaceuticals files to sell common stock, no amount given » 16:02
10/13/20
10/13
16:02
10/13/20
16:02
ETON

Eton Pharmaceuticals

$6.91 /

+ (+0.00%)

National Securities…

National Securities Corporation, a wholly owned subsidiary of National Holdings is acting as the sole book-running manager of the offering.

ShowHide Related Items >><<
ETON Eton Pharmaceuticals
$6.91 /

+ (+0.00%)

ETON Eton Pharmaceuticals
$6.91 /

+ (+0.00%)

09/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $20 from $18 at H.C. Wainwright
07/28/20 Lake Street
Eton 'on cusp' of generating significant shareholder value, says Lake Street
05/26/20 H.C. Wainwright
Eton Pharmaceuticals price target lowered to $18 from $26 at H.C. Wainwright
03/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $26 from $23 at H.C. Wainwright
ETON Eton Pharmaceuticals
$6.91 /

+ (+0.00%)

ETON Eton Pharmaceuticals
$6.91 /

+ (+0.00%)

Hot Stocks
Eton announces acceptance of NDA filing for dehydrated alcohol injection » 08:02
10/08/20
10/08
08:02
10/08/20
08:02
ETON

Eton Pharmaceuticals

$6.92 /

+0.25 (+3.75%)

Eton Pharmaceuticals…

Eton Pharmaceuticals announced the U.S. Food and Drug Administration has accepted for filing the company's new drug application for dehydrated alcohol injection. The application has been assigned a Prescription Drug User Fee Act date of May 27, 2021. Eton's application previously received orphan drug designation for the treatment of methanol poisoning and is expected to receive seven years of market exclusivity upon its approval.

ShowHide Related Items >><<
ETON Eton Pharmaceuticals
$6.92 /

+0.25 (+3.75%)

ETON Eton Pharmaceuticals
$6.92 /

+0.25 (+3.75%)

09/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $20 from $18 at H.C. Wainwright
07/28/20 Lake Street
Eton 'on cusp' of generating significant shareholder value, says Lake Street
05/26/20 H.C. Wainwright
Eton Pharmaceuticals price target lowered to $18 from $26 at H.C. Wainwright
03/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $26 from $23 at H.C. Wainwright
ETON Eton Pharmaceuticals
$6.92 /

+0.25 (+3.75%)

ETON Eton Pharmaceuticals
$6.92 /

+0.25 (+3.75%)

On The Fly
Fly Intel: After-Hours Movers » 18:39
10/06/20
10/06
18:39
10/06/20
18:39
LEVI

Levi Strauss

$14.75 /

-0.24 (-1.60%)

, IART

Integra LifeSciences

$48.86 /

+0.35 (+0.72%)

, SIRI

Sirius XM

$5.55 /

-0.06 (-1.07%)

, ETON

Eton Pharmaceuticals

$6.67 /

-0.31 (-4.44%)

, LNDC

Landec

$10.54 /

+0.53 (+5.29%)

, NSTG

NanoString

$43.68 /

-0.53 (-1.20%)

, CLSK

CleanSpark

$12.47 /

+0.24 (+1.96%)

, GH

Guardant Health

$110.07 /

-0.71 (-0.64%)

Check out this evening's…

ShowHide Related Items >><<
SIRI Sirius XM
$5.55 /

-0.06 (-1.07%)

NSTG NanoString
$43.68 /

-0.53 (-1.20%)

LNDC Landec
$10.54 /

+0.53 (+5.29%)

LEVI Levi Strauss
$14.75 /

-0.24 (-1.60%)

IART Integra LifeSciences
$48.86 /

+0.35 (+0.72%)

GH Guardant Health
$110.07 /

-0.71 (-0.64%)

ETON Eton Pharmaceuticals
$6.67 /

-0.31 (-4.44%)

CLSK CleanSpark
$12.47 /

+0.24 (+1.96%)

LEVI Levi Strauss
$14.75 /

-0.24 (-1.60%)

06/16/20 Exane BNP Paribas
Levi Strauss initiated with an Outperform at Exane BNP Paribas
04/09/20 Guggenheim
Levi Strauss price target lowered to $16 from $26 at Guggenheim
04/08/20 Citi
Levi Strauss has ample liquidity and remains 'strong brand,' says Citi
03/18/20 BofA
Levi Strauss downgraded to Neutral with $15 price target at BofA
IART Integra LifeSciences
$48.86 /

+0.35 (+0.72%)

09/30/20 Canaccord
Smith & Nephew acquisition helps leverage its strong position, says Canaccord
08/12/20 Truist
Integra LifeSciences price target raised to $60 from $55 at Truist
08/11/20 Oppenheimer
Integra LifeSciences price target raised to $68 from $60 at Oppenheimer
07/09/20 Piper Sandler
Piper Sandler remains 'apprehensive' on Integra LifeSciences after Q2 revenue
SIRI Sirius XM
$5.55 /

-0.06 (-1.07%)

10/06/20 Credit Suisse
Sirius XM upgraded to Outperform from Neutral at Credit Suisse
10/06/20 Credit Suisse
Sirius XM upgraded to Outperform from Neutral at Credit Suisse
10/01/20 JPMorgan
Sirius XM pullback brings 'compelling opportunity,' says JPMorgan
10/01/20 Pivotal Research
Sirius XM recent pullback a buying opportunity, says Pivotal Research
ETON Eton Pharmaceuticals
$6.67 /

-0.31 (-4.44%)

09/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $20 from $18 at H.C. Wainwright
07/28/20 Lake Street
Eton 'on cusp' of generating significant shareholder value, says Lake Street
05/26/20 H.C. Wainwright
Eton Pharmaceuticals price target lowered to $18 from $26 at H.C. Wainwright
03/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $26 from $23 at H.C. Wainwright
LNDC Landec
$10.54 /

+0.53 (+5.29%)

06/30/20
Fly Intel: Top five analyst downgrades
06/30/20 Lake Street
Landec price target raised to $11 after revenue beat at Lake Street
06/30/20 Barrington
Landec downgraded to Market Perform from Outperform at Barrington
04/21/20 Roth Capital
Landec upgraded to Buy from Neutral at Roth Capital
NSTG NanoString
$43.68 /

-0.53 (-1.20%)

09/09/20 Morgan Stanley
Veracyte initiated with an Underweight at Morgan Stanley
09/09/20 Morgan Stanley
NanoString initiated with an Equal Weight at Morgan Stanley
05/11/20 Baird
NanoString price target raised to $34 from $29 at Baird
03/11/20 JPMorgan
JPMorgan continues to recommend select exposure to Life Science Tools
CLSK CleanSpark
$12.47 /

+0.24 (+1.96%)

GH Guardant Health
$110.07 /

-0.71 (-0.64%)

09/09/20 Morgan Stanley
Guardant Health initiated with an Overweight at Morgan Stanley
08/10/20 Canaccord
Guardion Health Sciences FDA approval landmark event, says Canaccord
06/12/20
Fly Intel: Top five analyst initiations
06/12/20 BTIG
BTIG starts genomic profiling test 'pioneer' Guardant Health at Buy
SIRI Sirius XM
$5.55 /

-0.06 (-1.07%)

NSTG NanoString
$43.68 /

-0.53 (-1.20%)

LNDC Landec
$10.54 /

+0.53 (+5.29%)

LEVI Levi Strauss
$14.75 /

-0.24 (-1.60%)

IART Integra LifeSciences
$48.86 /

+0.35 (+0.72%)

GH Guardant Health
$110.07 /

-0.71 (-0.64%)

ETON Eton Pharmaceuticals
$6.67 /

-0.31 (-4.44%)

  • 07
    Oct
  • 07
    Oct
  • 08
    Oct
  • 02
    Jun
  • 22
    Nov
SIRI Sirius XM
$5.55 /

-0.06 (-1.07%)

LEVI Levi Strauss
$14.75 /

-0.24 (-1.60%)

SIRI Sirius XM
$5.55 /

-0.06 (-1.07%)

LEVI Levi Strauss
$14.75 /

-0.24 (-1.60%)

IART Integra LifeSciences
$48.86 /

+0.35 (+0.72%)

GH Guardant Health
$110.07 /

-0.71 (-0.64%)

ETON Eton Pharmaceuticals
$6.67 /

-0.31 (-4.44%)

SIRI Sirius XM
$5.55 /

-0.06 (-1.07%)

LNDC Landec
$10.54 /

+0.53 (+5.29%)

LEVI Levi Strauss
$14.75 /

-0.24 (-1.60%)

CLSK CleanSpark
$12.47 /

+0.24 (+1.96%)

Hot Stocks
Eton Pharmaceuticals submits NDA to FDA for topiramate oral solution » 16:11
10/06/20
10/06
16:11
10/06/20
16:11
ETON

Eton Pharmaceuticals

$6.65 /

-0.33 (-4.73%)

Eton Pharmaceuticals…

Eton Pharmaceuticals announced that in tandem with its development and manufacturing partner Tulex Pharmaceuticals, it has submitted a new drug application, NDA, for topiramate oral solution to the U.S. Food & Drug Administration, FDA. The product candidate, formerly known as ET-101, was submitted for three indications, including: monotherapy for treatment of partial-onset or primary general tonic-clonic seizures in patients two years age and older; adjunctive therapy for treatment of partial-onset seizures, including seizures associated with Lennox-Gastaut syndrome in patients two years of age and older; and as preventative treatment of migraine in patients 12 years of age and older. "Topiramate is one of the most widely compounded oral liquids, and our product addresses the unmet need for pediatric-friendly formulations of the molecule. We look forward to working with the FDA to bring a safe, effective, FDA-approved product to patients and caregivers as quickly as possible," said Sean Brynjelsen, CEO of Eton Pharmaceuticals. Eton's product is expected to be the first and only FDA-approved liquid formulation of topiramate. The company's patent-pending liquid formulation addresses the significant unmet need for patients with dysphagia and patients that require the precision dosing that a liquid can offer. Topiramate is currently FDA-approved only in tablet and capsule form. Based on IQVIA data, the market for oral topiramate is more than $800M annually. ET-101 is Eton's third neurology-focused liquid product candidates to be submitted to the FDA. Eton expects all three of the neurology product candidates to be approved and launched in 2021.

ShowHide Related Items >><<
ETON Eton Pharmaceuticals
$6.65 /

-0.33 (-4.73%)

ETON Eton Pharmaceuticals
$6.65 /

-0.33 (-4.73%)

09/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $20 from $18 at H.C. Wainwright
07/28/20 Lake Street
Eton 'on cusp' of generating significant shareholder value, says Lake Street
05/26/20 H.C. Wainwright
Eton Pharmaceuticals price target lowered to $18 from $26 at H.C. Wainwright
03/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $26 from $23 at H.C. Wainwright
ETON Eton Pharmaceuticals
$6.65 /

-0.33 (-4.73%)

ETON Eton Pharmaceuticals
$6.65 /

-0.33 (-4.73%)

On The Fly
Fly Intel: Pre-market Movers » 08:53
09/30/20
09/30
08:53
09/30/20
08:53
CZR

Caesars

$54.48 /

-3.75 (-6.44%)

, DUK

Duke Energy

$82.45 /

-0.38 (-0.46%)

, ETON

Eton Pharmaceuticals

$7.82 /

-0.19 (-2.37%)

, TH

Target Hospitality

$1.20 /

-0.025 (-2.04%)

, SNX

Synnex

$132.10 /

+0.6 (+0.46%)

, PRGS

Progress Software

$38.76 /

+1.47 (+3.94%)

, MU

Micron

$50.71 /

+0.98 (+1.97%)

, OAS

Oasis Petroleum

$0.40 /

-0.0093 (-2.27%)

, DIS

Disney

$125.31 /

-0.69 (-0.55%)

, RUN

Sunrun

$72.79 /

+0.82 (+1.14%)

Check out this morning's…

ShowHide Related Items >><<
TH Target Hospitality
$1.20 /

-0.025 (-2.04%)

SNX Synnex
$132.10 /

+0.6 (+0.46%)

RUN Sunrun
$72.79 /

+0.82 (+1.14%)

PRGS Progress Software
$38.76 /

+1.47 (+3.94%)

OAS Oasis Petroleum
$0.40 /

-0.0093 (-2.27%)

MU Micron
$50.71 /

+0.98 (+1.97%)

ETON Eton Pharmaceuticals
$7.82 /

-0.19 (-2.37%)

DUK Duke Energy
$82.45 /

-0.38 (-0.46%)

DIS Disney
$125.31 /

-0.69 (-0.55%)

CZR Caesars
$54.48 /

-3.75 (-6.44%)

CZR Caesars
$54.48 /

-3.75 (-6.44%)

09/30/20 Stifel
Caesars price target raised to $80 from $67 at Stifel
09/29/20 Jefferies
William Hill joint venture structure could impede takeout value, says Jefferies
09/28/20 Jefferies
Jefferies sees 'clear positives' in Caesars bid for William Hill
09/28/20 Roth Capital
Roth Capital sees currently uncaptured value for both Caesars, William Hill
DUK Duke Energy
$82.45 /

-0.38 (-0.46%)

09/09/20 BofA
Duke Energy upgraded to Buy from Neutral at BofA
09/09/20 BofA
Duke Energy upgraded to Buy from Neutral at BofA
07/07/20 Argus
Dominion price target lowered to $80 from $87 at Argus
07/06/20 Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
ETON Eton Pharmaceuticals
$7.82 /

-0.19 (-2.37%)

09/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $20 from $18 at H.C. Wainwright
07/28/20 Lake Street
Eton 'on cusp' of generating significant shareholder value, says Lake Street
05/26/20 H.C. Wainwright
Eton Pharmaceuticals price target lowered to $18 from $26 at H.C. Wainwright
03/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $26 from $23 at H.C. Wainwright
TH Target Hospitality
$1.20 /

-0.025 (-2.04%)

04/01/20 Northland
Northland downgrades Target Hospitality on oil market deterioration
04/01/20 Northland
Target Hospitality downgraded to Market Perform from Outperform at Northland
03/10/20 Stifel
Target Hospitality downgraded to Hold from Buy at Stifel
02/28/20 Deutsche Bank
Target Hospitality downgraded to Hold from Buy at Deutsche Bank
SNX Synnex
$132.10 /

+0.6 (+0.46%)

09/30/20 Loop Capital
Synnex price target raised to $170 from $140 at Loop Capital
09/30/20 Raymond James
Synnex price target raised to $160 from $140 at Raymond James
09/30/20 Citi
Synnex price target raised to $180 from $150 at Citi
06/26/20 Barrington
Synnex price target raised to $125 from $115 at Barrington
PRGS Progress Software
$38.76 /

+1.47 (+3.94%)

08/26/20 Wedbush
Progress Software assumed with an Outperform at Wedbush
06/26/20 Benchmark
Progress Software price target raised to $43 from $39 at Benchmark
01/17/20 Benchmark
Progress Software price target raised to $57 from $49 at Benchmark
10/22/19 Sidoti
Progress Software initiated with a Buy at Sidoti
MU Micron
$50.71 /

+0.98 (+1.97%)

09/30/20 Needham
Micron price target lowered to $65 from $70 at Needham
09/30/20 JPMorgan
JPMorgan sees 'good opportunity' to get long Micron shares
09/30/20 Wedbush
No clear turning point yet for Micron, says Wedbush
09/30/20 Deutsche Bank
Micron price target raised to $51 from $48 at Deutsche Bank
OAS Oasis Petroleum
$0.40 /

-0.0093 (-2.27%)

08/06/20 MKM Partners
Oasis Petroleum downgraded to Neutral from Buy at MKM Partners
08/06/20 MKM Partners
Oasis Petroleum downgraded to Neutral from Buy at MKM Partners
06/09/20 Citi
Oasis Petroleum downgraded to Sell from Neutral at Citi
06/09/20 Citi
Oasis Petroleum downgraded to Sell from Neutral at Citi
DIS Disney
$125.31 /

-0.69 (-0.55%)

09/28/20 Benchmark
Benchmark says market continues overestimating Netflix's 'sustainable dominance'
09/24/20 Needham
Disney Q4 revenue, earnings outlook lowered at Needham
09/14/20 Jefferies
ESPN deal positive for both Caesars and DraftKings, says Jefferies
09/14/20 Evercore ISI
ESPN deal could add up to material dollars for DraftKings, says Evercore
RUN Sunrun
$72.79 /

+0.82 (+1.14%)

09/30/20 JPMorgan
Sunrun price target raised to $79 from $61 at JPMorgan
09/30/20 Goldman Sachs
Sunrun downgraded to Neutral from Buy at Goldman Sachs
08/21/20 Barclays
Sunrun price target raised to $57 from $50 at Barclays
08/11/20 Oppenheimer
Sunrun price target raised to $55 from $23 at Oppenheimer
TH Target Hospitality
$1.20 /

-0.025 (-2.04%)

SNX Synnex
$132.10 /

+0.6 (+0.46%)

RUN Sunrun
$72.79 /

+0.82 (+1.14%)

PRGS Progress Software
$38.76 /

+1.47 (+3.94%)

OAS Oasis Petroleum
$0.40 /

-0.0093 (-2.27%)

MU Micron
$50.71 /

+0.98 (+1.97%)

ETON Eton Pharmaceuticals
$7.82 /

-0.19 (-2.37%)

DUK Duke Energy
$82.45 /

-0.38 (-0.46%)

DIS Disney
$125.31 /

-0.69 (-0.55%)

CZR Caesars
$54.48 /

-3.75 (-6.44%)

  • 29
    Sep
  • 19
    Nov
OAS Oasis Petroleum
$0.40 /

-0.0093 (-2.27%)

MU Micron
$50.71 /

+0.98 (+1.97%)

DUK Duke Energy
$82.45 /

-0.38 (-0.46%)

DIS Disney
$125.31 /

-0.69 (-0.55%)

CZR Caesars
$54.48 /

-3.75 (-6.44%)

SNX Synnex
$132.10 /

+0.6 (+0.46%)

RUN Sunrun
$72.79 /

+0.82 (+1.14%)

OAS Oasis Petroleum
$0.40 /

-0.0093 (-2.27%)

MU Micron
$50.71 /

+0.98 (+1.97%)

ETON Eton Pharmaceuticals
$7.82 /

-0.19 (-2.37%)

DUK Duke Energy
$82.45 /

-0.38 (-0.46%)

DIS Disney
$125.31 /

-0.69 (-0.55%)

CZR Caesars
$54.48 /

-3.75 (-6.44%)

SNX Synnex
$132.10 /

+0.6 (+0.46%)

RUN Sunrun
$72.79 /

+0.82 (+1.14%)

OAS Oasis Petroleum
$0.40 /

-0.0093 (-2.27%)

MU Micron
$50.71 /

+0.98 (+1.97%)

DUK Duke Energy
$82.45 /

-0.38 (-0.46%)

DIS Disney
$125.31 /

-0.69 (-0.55%)

CZR Caesars
$54.48 /

-3.75 (-6.44%)

Recommendations
Eton Pharmaceuticals price target raised to $20 from $18 at H.C. Wainwright » 06:15
09/30/20
09/30
06:15
09/30/20
06:15
ETON

Eton Pharmaceuticals

$7.82 /

-0.19 (-2.37%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Raghuram Selvaraju raised the firm's price target on Eton Pharmaceuticals to $20 from $18 and reiterates a Buy rating on the shares after the FDA approved Alkindi Sprinkle. Eton currently has three more product candidates under review at the FDA, Selvaraju tells investors in a research note.

ShowHide Related Items >><<
ETON Eton Pharmaceuticals
$7.82 /

-0.19 (-2.37%)

ETON Eton Pharmaceuticals
$7.82 /

-0.19 (-2.37%)

07/28/20 Lake Street
Eton 'on cusp' of generating significant shareholder value, says Lake Street
05/26/20 H.C. Wainwright
Eton Pharmaceuticals price target lowered to $18 from $26 at H.C. Wainwright
03/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $26 from $23 at H.C. Wainwright
01/28/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $23 from $21 at H.C. Wainwright
ETON Eton Pharmaceuticals
$7.82 /

-0.19 (-2.37%)

ETON Eton Pharmaceuticals
$7.82 /

-0.19 (-2.37%)

Over a month ago
Hot Stocks
Eton Pharmaceuticals announces FDA approval of ALKINDI SPRINKLE » 18:51
09/29/20
09/29
18:51
09/29/20
18:51
ETON

Eton Pharmaceuticals

$7.82 /

-0.19 (-2.37%)

Eton Pharmaceuticals…

Eton Pharmaceuticals announced that the U.S. FDA has approved ALKINDI SPRINKLE (hydrocortisone) oral granules as replacement therapy for Adrenocortical Insufficiency in children under 17 years of age. ALKINDI SPRINKLE is the first and only FDA-approved granular hydrocortisone formulation for the treatment of adrenocortical insufficiency specifically designed for use in children.

ShowHide Related Items >><<
ETON Eton Pharmaceuticals
$7.82 /

-0.19 (-2.37%)

ETON Eton Pharmaceuticals
$7.82 /

-0.19 (-2.37%)

07/28/20 Lake Street
Eton 'on cusp' of generating significant shareholder value, says Lake Street
05/26/20 H.C. Wainwright
Eton Pharmaceuticals price target lowered to $18 from $26 at H.C. Wainwright
03/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $26 from $23 at H.C. Wainwright
01/28/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $23 from $21 at H.C. Wainwright
ETON Eton Pharmaceuticals
$7.82 /

-0.19 (-2.37%)

ETON Eton Pharmaceuticals
$7.82 /

-0.19 (-2.37%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.